Trends in Cardiovascular Medicine
Volume 17, Issue 3 , Pages 105-111, April 2007

NR4A Nuclear Receptors in Atherosclerosis and Vein-Graft Disease

  • Peter I. Bonta
  • ,
  • Thijs W.H. Pols
  • ,
  • Carlie J.M. de Vries

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Dr. Carlie J.M. de Vries, Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands. Tel.: (+31) 205665152

Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands.

Nur77, Nurr1, and NOR-1 form the NR4A subfamily of the nuclear hormone receptor superfamily of transcription factors and have been described in the regulation of differentiation, proliferation, apoptosis, and survival of many different cell types. The expression of NR4A nuclear receptors in vascular pathologies has only recently been revealed, after which studies on the functional involvement of NR4A receptors in vascular disease were initiated. This review summarizes our current view on involvement of Nur77, Nurr1, and NOR-1 in atherosclerotic vascular disease and discusses NR4A function in vascular response to injury.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1050-1738(07)00044-8

doi:10.1016/j.tcm.2007.02.001

Trends in Cardiovascular Medicine
Volume 17, Issue 3 , Pages 105-111, April 2007